# STOCKHOLM 1.0
#=GF ID   Pribosyl_synth
#=GF AC   PF14572.10
#=GF DE   Phosphoribosyl synthetase-associated domain
#=GF AU   Coggill P;0000-0001-5731-1588
#=GF SE   pdb_2c4k; Jackhmmer:Q14558
#=GF GA   27.00 27.00;
#=GF TC   27.00 27.00;
#=GF NC   26.90 26.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 -Z 75585367 --cpu 4 HMM pfamseq
#=GF TP   Domain
#=GF WK   Ribose-phosphate_diphosphokinase
#=GF CL   CL0533
#=GF RN   [1]
#=GF RM   9545573
#=GF RT   Molecular cloning of a human cDNA for the 41-kDa
#=GF RT   phosphoribosylpyrophosphate synthetase-associated protein.
#=GF RA   Katashima R, Iwahana H, Fujimura M, Yamaoka T, Ishizuka T,
#=GF RA   Tatibana M, Itakura M;
#=GF RL   Biochim Biophys Acta. 1998;1396:245-250.
#=GF RN   [2]
#=GF RM   18409517
#=GF RT   [Increased activity of PRPP synthetase].
#=GF RA   Iizasa T;
#=GF RL   Nihon Rinsho. 2008;66:694-698.
#=GF DR   INTERPRO; IPR005946;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   This family includes several examples of enzymes from class
#=GF CC   EC:2.7.6.1, phosphoribosyl-pyrophosphate transferase.
#=GF SQ   6
#=GS Q23166_CAEEL/167-347  AC Q23166.1
#=GS Q961V3_DROME/165-361  AC Q961V3.1
#=GS E9FWJ1_DAPPU/165-348  AC E9FWJ1.1
#=GS KPRB_HUMAN/179-363    AC O60256.1
#=GS A7T9J2_NEMVE/4-194    AC A7T9J2.1
#=GS B3S6Z0_TRIAD/157-339  AC B3S6Z0.1
Q23166_CAEEL/167-347             DYKNAIIVAKSPGVMNKATSYADRLRLGVAVIHGEQKDEEESGLEDGRQSPPPN.................VTSYDF..LPAQESKQKPPLTVVGDVGGRIAIMVDDIIDDAQSFVAAAEVLKARGAYKIYVIATHGVLSSDAPALLEASPITEVIVTNTVPHDLQKMRCHKIKTVDVSLMICEAIRRIFHNESMGQLFR
Q961V3_DROME/165-361             DYRNSVIVARNPGVAKKANSYAERLRLGLAVIHGEQKETDADE.VDGRYSPPPTRNSTPQHAPTSSARQRTTSVSVG..VPEHIVKVKPPLTIVGDVSGRIAIMVDDLIDDVQAFVAAAEMLKENGACKIYVLATHGLLSSDAPRQLDESPIDEIVVTNTIPHEIQKLQCHKIKTIDISILIAEAIRRIHNKESMSYLFR
E9FWJ1_DAPPU/165-348             DFRNAVIVARDPGSAKKATSYAERLRLGIAVIHGEQKEAESDM.VDGRHSPPTLRS.............RTMDAARG..MPVMTAKEKPPINVVGDVGGRIAIMVDDMIDDVRSFVAAAEVLKDRGAYKIYVMATHGLLSSDAPRLIEDSPIDEVVVTNTIPHEIQKMQCHKIKTVDISVLLAEAIRRIHNKESMSYLFR
KPRB_HUMAN/179-363               DYRNAVIVAKSPASAKRAQSFAERLRLGIAVIHGEAQDAESDL.VDGRHSPPMVRS............VAAIHPSLE..IPMLIPKEKPPITVVGDVGGRIAIIVDDIIDDVDSFLAAAETLKERGAYKIFVMATHGLLSSDAPRRIEESAIDEVVVTNTIPHEVQKLQCPKIKTVDISMILSEAIRRIHNGESMSYLFR
A7T9J2_NEMVE/4-194               DCRNAVIVAKNPASAQRATSFAERLRLGIAVIHGEQKESEGDQ.CDGRQSPPPKPENSI......GFNFVPLENELN..VPGFLPKEKPPMNVVGDVGGKIAIIVDDMIDDATTFVDAARLLRDRGAYKIYVMVTHGLLSGSAPELIEGSEIDEVVVTNTVPHDSKVARCSKIKTIDISQLLAEAVRRIHNGESMGYLFR
B3S6Z0_TRIAD/157-339             DYKNAVVVAREPGSTKRATSFAERLHLTLAVIHGESKSDYYDE.DGSGSPPPEYDD.............SSVSRVLPSVLPEIAPKEKPPMTLVGDVTGKIAIIIDDMIDNLDLLLKAAELLEERGAYKIYALATHGQFTQSDAAKLDASCLEEIVVTNTIPQKI...NSSKLKTIDISQLIAESIRRIHNGESMSYLFR
#=GC seq_cons                    DYRNAVIVA+sPGSAK+ATSaAERLRLGlAVIHGEQK-sEuDt.sDGRpSPPshcs.............tslsssls..lPthhsKEKPPlTVVGDVGGRIAIhVDDhIDDlpoFVAAAElLK-RGAYKIYVhATHGLLSSDAPchlEsSsIDEVVVTNTIPH-lQKhpCpKIKTlDIShLlAEAIRRIHNsESMSYLFR
